Ora Biomedical video: 10,000 longevity experiments, peptides and resilience
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedIn this video description, Ora Biomedical's CEO and CSO describe screening interventions for lifespan and healthspan, including about 300 peptides, and an emerging focus on resilience; the description reports a longevity-associated compound that reduced radiation dermatitis burden by about 40% in a mouse model. [1]
The description says the episode covers Ora's systematic screening of interventions for lifespan and healthspan, including a screen of roughly 300 peptides and lessons from nearly 10,000 intervention experiments. [1]
The description says resilience led Ora from lifespan studies in C. elegans to UV and radiation resistance, human skin cells, animal studies and possible applications such as photoaging, cancer radiation therapy and radiation protection for pilots and astronauts. [1]
The description reports early pipeline results including a longevity-associated compound that reduced radiation dermatitis burden by approximately 40% in a mouse model. [1]
Ora's screening of peptides and 10,000 experiments
According to the description, the episode is an update on Ora Biomedical's effort to systematically screen interventions for effects on lifespan and healthspan. The hosts describe the Million Molecule Challenge and new results from a screen of roughly 300 peptides, including known peptides, AI-predicted candidates and structurally diverse molecules. They also discuss what Ora is beginning to learn from nearly 10,000 intervention experiments and why existing datasets may not be sufficient to predict longevity therapeutics with AI. [1]
Resilience: from worms to UV, radiation and skin
The description says an unexpected direction is resilience: rather than asking only whether a molecule extends lifespan, can longevity interventions improve the body's ability to recover from damage? That question reportedly led Ora from lifespan studies in C. elegans to UV and radiation resistance, human skin cells, animal studies and potential applications such as photoaging, cancer radiation therapy and protecting pilots and astronauts from radiation exposure. Early pipeline results mentioned include a longevity-associated compound that reduced radiation dermatitis burden by approximately 40% in a mouse model, and work on natural products that may improve recovery from UV damage. [1]
Translation from worms to humans and disclosure
The description states that the conversation also covers the challenge of translating discoveries from worms into humans and whether resilience could offer a practical path for testing longevity therapeutics on a much shorter timescale. The host discloses that he is a co-founder of Ora Biomedical, serves on its Board of Directors and has a financial interest in the company, so viewers can weigh this potential conflict of interest. The description also carries a general educational disclaimer and states that the information is not personalized medical advice. [1]
Context & limits
This is based only on the supplied video description; the video and transcript were not reviewed. The description reports no study designs, sample sizes, follow-up or statistical uncertainty for the cited results, and the approximately 40% reduction comes from a mouse model, not humans. The host discloses a financial interest in Ora Biomedical.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
systematically screen interventions for effects on lifespan
from lifespan studies in C. elegans to
reduced radiation dermatitis burden by approximately 40%
About this video
Creator description · original textText language: American English
Matt Kaeberlein · 43 min · Source published: 2026-10-06
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.